The prevalence of PSCC in the general population may be estimated with fair accuracy.
Considering only patients 65 years of age or older, 0.3 percent of the hospital beds of Great …

• While the cataractogenic effects of corticosteroids are beyond dispute, disagreement exists
concerning effects of total dose, intensity of dose, and duration of administration on cataract …

Introduction The relationship between long-term systemic corticosteroid therapy and the
development of posterior subcapsular cataracts (PSC) has been reviewed by Straatsma. 1 …

Background The use of systemic corticosteroids is a risk factor for the development of
posterior subcapsular cataracts, but the association between inhaled corticosteroids and …

With the exception of antibiotics few new medicines would seem to have achieved such
frequent and wide-spread application in our time as cortisoneintroduced by Hench and his …

Centrally placed opacities lying under the capsuleatthe posteriorpart of the lens-posterior
subcapsular cataracts (PSC)-have beenreported in 12.5 to 6o per cent.(mean 36-7 per cent.) …

OBJECTIVE:: Longitudinal associations between inhaled and oral corticosteroid use and 10-
year incident cataract were examined. DESIGN: Population-based cohort study …

Most common side effects of systemic corticosteroids are posterior subcapsular cataract and
glaucoma. There is no way to prevent corticosteroid-induced cataract. The risk of these …

A group of 56 patients who had received sustained, systemic corticosteroid therapy were
examined in order to determine the incidence of posterior subcapsular cataracts. Thirty-eight …

Background/aims: Exposure to systemic corticosteroid use is known to be associated with a
risk of cataract. Whether low doses of inhaled corticosteroids are associated with an …